Beijing T&L Biotechnology Co.,Ltd.
同立海源
Beijing T&L Biotechnology Co.,Ltd.
Biotech/Healthcare
Beijing Tongli Haiyuan Biotechnology Co., Ltd. focuses on the development of GMP-grade upstream raw materials and reagents for cell and gene therapy (CGT), providing reliable products and services for the life sciences.
Latest round: Series B (2025)
Source: ChinaBulls — chinabulls.com
Last updated 2025-06-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.